Skip to content

Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01782820
Enrollment
108
Registered
2013-02-04
Start date
2011-12-31
Completion date
2013-01-31
Last updated
2022-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Block, Dexamethasone, Neuromuscular Block, Recovery

Brief summary

The aim of the present study is to compare the time course of a neuromuscular block in patients receiving dexamethasone 8 mg in order to reduce postoperative nausea or vomiting several hours before surgery with patients receiving the drug immediately before induction of anaesthesia and patients without a dexamethasone prophylaxis. The primary end point is the time from start of injection of rocuronium until recovery to a train of four ratio (TOF ratio) of 0.9.

Interventions

None listed

Sponsors

Kreiskrankenhaus Dormagen
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients aged 18 to 65 years, * American Society of Anesthesiologists Physical Status I or II, * 50-90 kg body weight, * undergoing elective laparoscopic gynaecological surgery in general anaesthesia necessitating intraoperative neuromuscular blockade.

Exclusion criteria

* expected difficulties with endotracheal intubation (history of difficult intubation, * reduced opening of the mouth (\< 2cm), and Mallampati Score of 4), * increased risk of pulmonary aspiration (gastrooesophageal reflux, full stomach, intestinal obstruction), * known allergies to the drugs tested, * pregnancy, * neuromuscular disorders, * intake of drugs affecting neuromuscular blockade, such as furosemide, magnesium or cephalosporins, * hepatic-or renal insufficiency.

Design outcomes

Primary

MeasureTime frame
the time from start of injection of rocuronium until recovery to a train of four ratio (TOF ratio) of 0.9.one hour

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026